Trials / Completed
CompletedNCT03145844
Direct Acting Agents in Hepatitis C Patients
Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,700 (actual)
- Sponsor
- Fehmi Tabak · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective study conducted at 36 sites. Planned target patient number is 1000.
Detailed description
Approximately 36 centers will be included in Turkey. Centers will be selected from clinics of infection and clinical microbiology. The inclusion of 1000 patients was targeted. All data will be retrospectively collected from the medical records of the patients. Patient visit is not necessary.
Conditions
Timeline
- Start date
- 2017-04-09
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2017-05-09
- Last updated
- 2019-10-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03145844. Inclusion in this directory is not an endorsement.